Use of organosilicon quaternary ammonium salt in preparation of medical material for typing diagnosis of prostatitis
By using organosilicon quaternary ammonium salt materials that form nanoscale or molecular-level tubular membranes within the urethra, the problem of false positives and false negatives in prostatitis subtyping caused by urethral contamination has been solved, achieving more accurate diagnosis and simplified procedures.
Patent Information
- Application Number
- CN202411296245.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-18
- Publication Date
- 2025-12-19
- Estimated Expiration
- 2044-09-18
AI Technical Summary
When obtaining prostatic fluid under non-invasive conditions, the urethra is easily contaminated by bacteria and white blood cells, leading to false positive or false negative results in the diagnosis of prostatitis subtypes. In addition, the operation is complicated and has a low application rate among doctors.
Organosilicon quaternary ammonium salts are used to prepare urethral biocompatible material membranes. These membranes can be self-assembled to form nanoscale or molecular-level tubular membranes, which can prevent or destroy bacterial biofilms, isolate bacteria and leukocytes, and improve the method of collecting prostatic fluid.
It effectively avoids urethral contamination, improves the accuracy of prostatitis classification diagnosis, simplifies operation, and increases the application rate among doctors.